As of Jun 23
| -0.01 / -0.53%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 3.00, with a high estimate of 3.25 and a low estimate of 1.50. The median estimate represents a +59.57% increase from the last price of 1.88.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.